Maine 2025-2026 Regular Session

Maine House Bill LD926

Introduced
3/5/25  
Refer
3/5/25  

Caption

An Act to Promote Research and Development in the State by Amending the Research Expense Tax Credit

Impact

If enacted, LD926 would have a substantial impact on state laws pertaining to business taxation and support for innovation. The bill sets specific performance measures for evaluating the effectiveness of the tax credit, focusing on factors such as the growth in research and development investments and the creation of high-wage jobs in the state. Additionally, it mandates annual reporting on the effectiveness of the credit, ensuring accountability and transparency in the administration of this financial incentive.

Summary

Legislative Document 926, titled 'An Act to Promote Research and Development in the State by Amending the Research Expense Tax Credit', aims to enhance the state's research and development landscape through significant changes to the existing tax credit structure. This bill proposes to increase the amount of expenditures eligible for the research expense tax credit, effectively doubling the rate at which the credit is calculated and the maximum claimable amount. By doing so, the legislators seek to stimulate investment in research activities that are crucial for economic growth and job creation within the state.

Sentiment

The sentiment surrounding LD926 appears largely positive among proponents who view it as a necessary step toward supporting businesses involved in research and development. Advocates argue that the enhanced tax credits will not only lead to increased investment within the state but also attract and retain high-quality jobs capable of bolstering the local economy. However, there may be caution expressed by some groups regarding the fiscal implications of expanding tax credits in an uncertain economic climate.

Contention

Notable points of contention regarding LD926 can arise around the effectiveness and sustainability of increased tax credits. Critics may argue that while the intention to boost research and development is commendable, such financial incentives could lead to significant revenue losses for the state. Opposition voices could raise concerns over whether tax credits translationally translate into actual investments and job creation, calling for careful monitoring and evaluation of the bill's outcomes once implemented.

Companion Bills

No companion bills found.

Previously Filed As

ME A2667

Increases qualified research expenses tax credit for corporation business taxpayers engaged in targeted industries; increases basic research payment tax credit; allows research tax credit to be refundable.

ME S3560

Increases qualified research expenses tax credit for corporation business taxpayers engaged in targeted industries; increases basic research payment tax credit; allows research tax credit to be refundable.

ME S1244

Research and Development Tax Credit

ME S1076

Research and Development Tax Credit

ME SB2206

Relating to a franchise tax credit for, and the application of sales and use taxes to, certain research and development expenses.

ME HB4393

Relating to a franchise tax credit for, and the application of sales and use taxes to, certain research and development expenses.

ME HB07008

An Act Concerning A Research And Development Expenses Tax Credit For Pass-through Entities.

ME H1377

Research and Development Tax Credit

ME H0847

Research and Development Tax Credit

ME A232

Provides research and development tax credit under gross income tax.

Similar Bills

HI SB1204

Relating To The University Of Hawaii.

HI SB1204

Relating To The University Of Hawaii.

CA AB1103

Controlled substances: research.

HI SB2657

Relating To Alzheimer's Disease And Related Dementias Research.

CA SB829

California Institute for Scientific Research: CalRx Initiative: vaccines.

HI HB1597

Relating To Alzheimer's Disease And Related Dementias Research.

NJ A4665

Permits certain transportation research contracts to be awarded to private research institutions of higher education and other entities.

AZ SB1722

Civil liability; fraudulent scientific research